Timothy P. Clackson

Insider Reports History

Entity
Individual
Location
C/O Ariad Pharmaceuticals Inc, 26 Landsdowne Street, Cambridge, MA
Signature
/s/ Robert Yang, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Timothy P. Clackson:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Theseus Pharmaceuticals, Inc. President and CEO, Director Restricted Stock Units 45.6K $139K $3.05 Mar 1, 2023 Direct
Xilio Therapeutics, Inc. 10%+ Owner Common Stock 70.9K $58.8K $0.83 Oct 21, 2021 The Timothy P. Clackson Irrevocable GST Trust of 2020
Elevation Oncology, Inc. Director Common Stock 47.3K $24.1K $0.51 Sep 1, 2023 The Timothy P. Clackson Irrevocable GST Trust of 2020
Xilio Therapeutics, Inc. 10%+ Owner Common Stock 20.1K $16.7K $0.83 Oct 21, 2021 Direct
Theseus Pharmaceuticals, Inc. President and CEO, Director Stock Option (right to buy) 274K Feb 17, 2023 Direct
Elevation Oncology, Inc. Director Stock Option (Right to Buy) 35K Jun 13, 2024 Direct
Elevation Oncology, Inc. Director Common Stock 0 $0.51 Sep 1, 2023 Direct
Forma Therapeutics Holdings, Inc. Director Common Stock 0 $5.05 Oct 14, 2022 Direct
Forma Therapeutics Holdings, Inc. Director Stock Option (Right to Buy) 0 Oct 14, 2022 Direct

Insider Reports Filed by Timothy P. Clackson

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ELEV Elevation Oncology, Inc. Jun 13, 2024 1 $0 4 Jun 17, 2024 Director
ELEV Elevation Oncology, Inc. Sep 1, 2023 1 $0 4 Sep 5, 2023 Director
ELEV Elevation Oncology, Inc. Jun 16, 2023 1 $0 4 Jun 21, 2023 Director
THRX Theseus Pharmaceuticals, Inc. Mar 1, 2023 1 $0 4 Mar 2, 2023 President and CEO, Director
THRX Theseus Pharmaceuticals, Inc. Feb 17, 2023 1 $0 4 Feb 21, 2023 President and CEO, Director
THRX Theseus Pharmaceuticals, Inc. Nov 11, 2022 1 $17K 4 Nov 14, 2022 President and CEO, Director
FMTX Forma Therapeutics Holdings, Inc. Oct 14, 2022 8 $0 4 Oct 14, 2022 Director
ELEV Elevation Oncology, Inc. Jun 17, 2022 2 $0 4 Jun 22, 2022 Director
FMTX Forma Therapeutics Holdings, Inc. Jun 8, 2022 2 $0 4 Jun 9, 2022 Director
THRX Theseus Pharmaceuticals, Inc. Feb 18, 2022 1 $0 4 Feb 23, 2022 President and CEO, Director
THRX Theseus Pharmaceuticals, Inc. Dec 21, 2021 1 $25.4K 4 Dec 22, 2021 President and CEO, Director
XLO Xilio Therapeutics, Inc. Oct 21, 2021 0 $0 3 Oct 21, 2021 10%+ Owner
THRX Theseus Pharmaceuticals, Inc. Oct 6, 2021 0 $0 3 Oct 6, 2021 President and CEO, Director
ELEV Elevation Oncology, Inc. Jun 24, 2021 0 $0 3 Jun 24, 2021 Director
FMTX Forma Therapeutics Holdings, Inc. Jun 17, 2021 2 $0 4 Jun 21, 2021 Director